Man Group’s Astera Labs ALAB Stock Holding History

Man Group’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$54.8K	Buy	+500	New	+$71.2K	﹤0.01%	2363

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Man Group's ALAB Position: Q1 2026 in Review

Man Group reduced its Astera Labs (ALAB) stake by 11% in Q1 2026, selling an estimated $624K and leaving 35,188 shares worth $3.86M. The position accounts for 0.01% of the portfolio, ranked #1287.

Man Group first reported a position in ALAB in Q4 2024 and has held it in 6 quarters since. The position peaked at $22.2M in Q3 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

Man Group held 35,188 shares of Astera Labs worth $3.86M as of Q1 2026.
Man Group sold 4,383 Astera Labs shares in Q1 2026, an estimated $624K.
Astera Labs made up 0.01% of Man Group's portfolio in Q1 2026, its #1287 holding.
Man Group first reported a position in Astera Labs in Q4 2024 and has held it in 6 quarters since.
Man Group's Astera Labs position peaked at $22.2M in Q3 2025.
703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.